Recent advances in the understanding and management of primary hyperparathyroidism

Melanie Goldfarb, Frederick R. Singer

Research output: Contribution to journalReview articlepeer-review

8 Scopus citations

Abstract

Primary hyperparathyroidism is a hormonal disorder whose prevalence is approximately 1-2% in the United States of America. The disease has become more recognizable to clinicians in an earlier phase and, at present, patients can be diagnosed with “classic”, “normocalcemic”, “normohormonal”, or “mild, asymptomatic” primary hyperparathyroidism. Surgery, with a focused parathyroidectomy when possible, or a four-gland exploration, is the only way to cure the disease. Cure is determined by use of intra-operative parathyroid hormone monitoring with long-term cure rates ranging from 90-95%. Newer adjuncts to surgery include CT or PET imaging and near-infrared immunofluorescence. This article highlights updates in parathyroid disease and advances in parathyroid surgery; it does not provide a comprehensive summary of the disease process or a review of surgical indications, which can be found in the AAES guidelines or NIH Symposium on primary hyperparathyroidism.

Original languageEnglish
Article number143
JournalF1000Research
Volume9
DOIs
StatePublished - 2020

Keywords

  • Primary hyperparathyroidism

Fingerprint

Dive into the research topics of 'Recent advances in the understanding and management of primary hyperparathyroidism'. Together they form a unique fingerprint.

Cite this